Citi is holding firm on its Sell rating for Hims & Hers Health, Inc. (NYSE:HIMS), according to a report released on June 3, keeping a $30 price target even as the company moves to expand its ...

Hers reports on harmful hair care ingredients. Avoid sulfates, parabens, silicones, and certain oils for healthier hair.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

The Novo Nordisk partnership ending does not alter my long-term bullish thesis on HIMS; the company is much more than just a ...

Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its ...

Novo Nordisk exits obesity-drug partnership with Hims & Hers, cites compounding concerns Hims wasn’t stepping back enough from its practice of mass marketing compounded versions of the weight ...

The partnership forged by Novo Nordisk (NVO) and Hims & Hers (HIMS) in April appeared to bring together two giant brands in ...

Start your journey to fuller-looking, thicker hair with a range of effective hair loss treatment options available through Hims & Hers - it's 100% online. No doctor's office visit needed ...

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company ...

Hims & Hers is only at 2.4 million active customers, and there are tens of millions of people in the United States alone who could start using or switch to one of its telehealth platforms.

Hims & Hers is perhaps best known in the U.S. for its direct-to-consumer offerings across categories such as hair loss, sexual health, and anxiety — but its compounded GLP-1 medications have ...

Hims & Hers will continue to offer its flagship products for sexual health, hair loss, mental health and weight loss. The company also teased the addition of new features for its European ...